We are live on ! Find out more
GA

General Atlantic Portfolio holdings

AUM $2.15B
1-Year Est. Return 35.02%
This Fund
S&P 500
This Quarter Est. Return
+16.69%
1 Year Est. Return
+35.02%
3 Year Est. Return
+185.68%
5 Year Est. Return
+122.28%
10 Year Est. Return
+1,080.07%
AUM
$8.49B
AUM Growth
+$832M
Cap. Flow
-$1.85M
Cap. Flow %
-0.02%
Top 10 Hldgs %
88.45%
Holding
40
New
2
Increased
7
Reduced
5
Closed
1

Sector Composition

Rank Sector Weight
1 Technology 51.31%
2 Healthcare 33.16%
3 Financials 5.67%
4 Industrials 5.34%
5 Consumer Staples 3.12%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ESMT
1
DELISTED
EngageSmart, Inc.
ESMT
$2.01B 23.69%
97,209,436
OSH
2
DELISTED
Oak Street Health, Inc.
OSH
$1.51B 17.73%
61,384,475
DLO icon
3
dLocal
DLO
$4.33B
$1.18B 13.85%
57,310,939
ALHC icon
4
Alignment Healthcare
ALHC
$3.73B
$722M 8.5%
60,993,323
-9,075,994
-13% -$132M
XP icon
5
XP
XP
$8.5B
$481M 5.67%
25,317,733
+4,842,000
+24% +$96.1M
SQSP
6
DELISTED
Squarespace, Inc.
SQSP
$478M 5.62%
22,361,073
HRT
7
DELISTED
HireRight Holdings Corporation
HRT
$454M 5.34%
29,719,898
ALKT icon
8
Alkami Technology
ALKT
$1.96B
$282M 3.32%
18,729,806
EWCZ
9
DELISTED
European Wax Center
EWCZ
$242M 2.85%
13,110,492
YOU icon
10
Clear Secure
YOU
$5.7B
$160M 1.89%
7,013,699
DUOL icon
11
Duolingo
DUOL
$6.54B
$141M 1.66%
1,479,294
-119,992
-8% -$11.7M
CINC
12
DELISTED
CinCor Pharma, Inc. Common Stock
CINC
$138M 1.63%
4,209,470
+83,000
+2% +$2.35M
DNA icon
13
Ginkgo Bioworks
DNA
$510M
$101M 1.19%
807,997
-927,896
-53% -$111M
KRTX
14
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
$93.3M 1.1%
+415,000
New +$84M
ETSY icon
15
Etsy
ETSY
$8.12B
$73.9M 0.87%
737,648
RPRX icon
16
Royalty Pharma
RPRX
$26.6B
$60.3M 0.71%
1,500,000
THRD
17
DELISTED
Third Harmonic Bio
THRD
$56.1M 0.66%
+2,958,762
New +$53.3M
IMCR icon
18
Immunocore
IMCR
$1.7B
$44.6M 0.53%
950,000
CNTA
19
DELISTED
Centessa Pharmaceuticals
CNTA
$38.9M 0.46%
9,681,818
HCM icon
20
HUTCHMED
HCM
$1.96B
$35.4M 0.42%
4,000,000
IOT icon
21
Samsara
IOT
$22.4B
$29.5M 0.35%
2,446,379
BLND icon
22
Blend Labs
BLND
$433M
$25.3M 0.3%
11,433,949
RSKD icon
23
Riskified
RSKD
$731M
$21M 0.25%
5,324,998
OPEN icon
24
Opendoor
OPEN
$3.75B
$19.7M 0.23%
6,532,236
PHVS icon
25
Pharvaris
PHVS
$2.34B
$18.6M 0.22%
2,420,155

Similar funds

General Atlantic's Q3 2022 Portfolio in Review

As of Q3 2022, General Atlantic held 40 positions worth $8.49B, up 11% from $7.66B the previous quarter. Its ten largest holdings account for 88% of the portfolio.

General Atlantic's Q3 2022 filing shows 2 new, 7 increased, 5 reduced and 1 closed positions. Its largest new stake was Karuna Therapeutics, Inc. Common Stock: 415,000 shares worth $93.3M. The largest sale was Alignment Healthcare, an estimated $132M.

By sector, the portfolio is most concentrated in Technology at 51% of assets, down from 55% a quarter earlier, followed by Healthcare and Financials.

  • General Atlantic's largest Q3 2022 buy was Karuna Therapeutics, Inc. Common Stock: 415,000 shares worth $93.3M.
  • General Atlantic added most to XP in Q3 2022, an estimated $96.1M increase.
  • General Atlantic's biggest Q3 2022 reduction was Alignment Healthcare, cutting an estimated $132M.
  • General Atlantic fully exited KnowBe4, Inc. Class A Common Stock in Q3 2022, selling an estimated $3.32M.
  • General Atlantic's ten largest holdings make up 88% of its $8.49B portfolio in Q3 2022.
  • General Atlantic opened 2 new positions and closed 1 in Q3 2022.
  • General Atlantic's portfolio value rose 11% quarter-over-quarter to $8.49B.

Based on General Atlantic's 13F filing for Q3 2022, filed 14 Nov 2022.